" /> Regorafenib Anhydrous - CISMeF





Preferred Label : Regorafenib Anhydrous;

NCIt synonyms : BAY 73-4506; 4-(4-(((4-chloro-3-(trifluoromethyl)phenyl)carbamoyl)amino)-3-fluorophenoxy)-N-methylpyridine-2-carboxamide; Multitargeted Receptor Tyrosine Kinase Inhibitor BAY 73-4506;

NCIt related terms : Regorafenib;

NCIt definition : The anhydrous form of regorafenib, an orally bioavailable small molecule with potential antiangiogenic and antineoplastic activities. Regorafenib binds to and inhibits vascular endothelial growth factor receptors (VEGFRs) 2 and 3, and Ret, Kit, PDGFR and Raf kinases, which may result in the inhibition of tumor angiogenesis and tumor cell proliferation. VEGFRs are receptor tyrosine kinases that play important roles in tumor angiogenesis; the receptor tyrosine kinases RET, KIT, and PDGFR, and the serine/threonine-specific Raf kinase are involved in tumor cell signaling.;

UNII : 24T2A1DOYB;

InChIKey : FNHKPVJBJVTLMP-UHFFFAOYSA-N;

CAS number : 755037-03-7;

Molecule name : BAY 734506; BAY 73 4506;

Chemical formula : C21H15ClF4N4O3;

Codes from synonyms : 438;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
04/07/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.